High levels of SHP-1 expression are related to high survival rates in patients with tumors, including breast cancer, esophageal squamous cell carcinoma, hepatocellular carcinoma, and prostate cancer [20,33,34,35,36,37]. Here, NR0B2 is linked to prostate carcinoma.